Moderna shareholder want to know why COVID-19 vaccine is so expensive | Fortune
Moderna on Twitter: "2021 was a year of monumental impact and change for # Moderna. Read our annual letter to shareholders, from our CEO Stephane Bancel: https://t.co/N26wYGviZv https://t.co/3ezD2MSZLG" / Twitter
Moderna 2022 Shareholder Letter – Moderna
From Pfizer to Moderna: who's making billions from Covid-19 vaccines? | Pharmaceuticals industry | The Guardian
With 65% institutional ownership, Moderna, Inc. (NASDAQ:MRNA) is a favorite amongst the big guns
Pharma investors, shareholders should not determine global health - STAT
AHF: Moderna Dodges Shareholders with Virtual AGM | Business Wire
Moderna and Pfizer urged to share vaccine technology with developing world | Financial Times
Moderna on Twitter: "Stéphane Bancel's annual letter to shareholders just published. Read the letter here: https://t.co/AAhJrhaO8z https://t.co/rqnCKu4IA1" / Twitter
Moderna sees higher COVID vaccine sales later this year | Reuters
Moderna CEO: No 'Crazy' Deals. We're Giving Cash to Shareholders. | Barron's
Moderna 2019 Shareholder Letter – Moderna
Surging Moderna Stock Mints The Vaccine Maker's Fifth Billionaire
UPDATED: Pfizer to join J&J, Moderna in shareholder vote showdown on vaccine pricing strategy, manufacturing tech sharing | Fierce Pharma
Pfizer, Moderna and J&J Face Shareholder Pressure to Broaden Covid-19 Vaccine Access - WSJ
AHF • Top Moderna Shareholders Must Dump Stock
S-1
Moderna, Inc.; Rule 14a-8 no-action letter
Utterly Obscene': Just 8 Pfizer and Moderna Investors Became $10 Billion Richer After Omicron Emerged
Moderna's Covid Boom Is Ending. Why the Outlook Isn't All Grim. | Barron's
Selling stock at a clip, top Moderna doctor gets $1 million richer each week
Moderna executives sell stock as coronavirus vaccine boosts company shares - The Washington Post
What Are the Risks for Moderna Shareholders? | The Motley Fool
